Stage IV pancreatic cancer tissues showed even higher levels of GFRAL expression than stage I. In addition, Kaplan–Meier analysis has shown that higher levels of GFRAL expression are associated with lower 5-year overall survival rates in patients. Here, GFRAL is linked to pancreatic neoplasm.